• Muneeza Taseer Postgraduate Medical Institute Lahore
  • Naima Shakeel Postgraduate Medical Institute Lahore
  • Munira Taseer Lahore General Hospital
  • Fawad Ammer ud Din Medical College Lahore
  • Faiza Rehman Ameer ud Din Medical College Lahore
  • Durrira Ameer ud Din Medical College Lahore



Background: The placenta is a complex transiently formed organ which plays a crucial role in the development of the foetus. As the placenta is responsible for maintaining pregnancy placental defects are mainly responsible for pregnancy-related issues. Preeclampsia is a pregnancy-related disorder due to uteroplacental insufficiency resulting from deficient remodelling of spiral arteries causing ischemic reperfusion injury which is finally responsible for the generation of reactive oxygen species and oxidative stress by the placenta. So, this study was planned to determine and compare serum levels of oxidative stress markers (ischemia-modified albumin and malondialdehyde) in preeclampsia and normal pregnancy in the third trimester. Methods: Study design: Cross-sectional comparative study Settings Gynae/Obs Department and Pathology Laboratory, Lahore General Hospital, Lahore. Study population: 42 Pregnant females at 34–36 weeks of gestation were selected. Group 1 compromised 21 normal healthy pregnant females and group 2 included 21 preeclamptic patients. Sampling technique: non-probability purposive sampling. Blood samples were taken at 34–36 weeks of gestation. Serum was stored for ischemia-modified albumin and malondialdehyde. Data was analyzed using SPSS version 20.  An Independent t-test was used to compare values between the groups during the third trimester. A p-value of ≤0.05 was considered significant. Results: Comparison of ischemia-modified albumin and malondialdehyde values between group I and group 2 showed a highly significant difference of p-value of <0.001. Conclusion: Oxidative stress markers were higher in preeclamptic patients as compared to normal pregnant females during the third trimester suggesting the role of the placenta in oxidative stress.

Author Biographies

Muneeza Taseer, Postgraduate Medical Institute Lahore


Naima Shakeel, Postgraduate Medical Institute Lahore



Zannat MR, Nessa A, Ferdousi S. Serum albumin in first and third trimester of pregnancy. Dinajpur Med Coll J 2016;9(2):216–20.

Toboła-Wróbel K, Pietryga M, Dydowicz P, Napierała M, Brązert J, Florek E. Association of oxidative stress on pregnancy. Oxid Med Cell Longev 2020;2020:6368520.

Pereira RD, De Long NE, Wang RC, Yazdi FT, Holloway AC, Raha S. Angiogenesis in the placenta: the role of reactive oxygen species signaling. Biomed Res Int 2015;2015:814543.

Schiattarella A, Lombardo M, Morlando M, Rizzo G. The impact of a plant-based diet on gestational diabetes: A review. Antioxidants (Basel) 2021;10(4):557.

Sharifi-Rad M, Anil Kumar NV, Zucca P, Varoni EM, Dini L, Panzarini E, et al. Lifestyle, oxidative stress, and antioxidants: back and forth in the pathophysiology of chronic diseases. Front Physiol 2020;11:694.

Ruano CS, Miralles F, Méhats C, Vaiman D. The Impact of Oxidative Stress of Environmental Origin on the Onset of Placental Diseases. Antioxidants (Basel) 2022;11(1):106.

Opichka MA, Rappelt MW, Gutterman DD, Grobe JL, McIntosh JJ. Vascular dysfunction in preeclampsia. Cells 2021;10(11):3055.

Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia—a preliminary report. J Emerg Med 2000;19(4):311–5.

Atiba AS, Abbiyesuku FM, Oparinde DP, Temitope A, Akindele RA. Plasma malondialdehyde (MDA): an indication of liver damage in women with pre-eclamsia. Ethiop J Health Sci 2016;26(5):479–86.

Shilpa AV, Zubaida PA, Rajalekshmi G. Changes in homocysteine levels during normal pregnancy and preeclampsia and its relation with oxidative stress. Int J Res Med Sci 2017;5(1):330–4.

Noh EJ, Kim YH, Cho MK, Kim JW, Kim JW, Byun YJ, et al. Comparison of oxidative stress markers in umbilical cord blood after vaginal and cesarean delivery. Obstet Gynecol Sci 2014;57(2):109–14.

Bahinipati J, Mohapatra PC. Ischemia modified albumin as a marker of oxidative stress in normal pregnancy. J Clin Diagn Res 2016;10(9):BC15.

Gafsou B, Lefèvre G, Hennache B, Debarge VH, Ducloy-Bouthors AS. Maternal serum ischemia-modified albumin: a biomarker to distinguish between normal pregnancy and preeclampsia? Hypertens Pregnancy 2010;29(1):101–11.

Kaushik K, Satwika S. Original Research Article Placental ischemia modified albumin may be a marker of oxidative stress in pre-eclampsia. Sch J App Med Sci 2016;4(1A):52–6.

Van Rijn BB, Franx A, Sikkema JM, van Rijn HJ, Bruinse HW, Voorbij HA. Ischemia modified albumin in normal pregnancy and preeclampsia. Hypertens Pregnancy 2008;27(2):159–67.

Vyakaranam S, Bhongir AV, Patlolla D, Chintapally R. Maternal serum ischemia modified albumin as a marker for hypertensive disorders of pregnancy: a pilot study. Int J Reprod Contracept Obstet Gynecol 2015;4(3):611–6.

Additional Files